Table 3.
T1 | iAUC | ADC | Volume | |
---|---|---|---|---|
Pre-treatment | ||||
CD31 | −0.07 (0.83) | −0.28 (0.37) | −0.16 (0.63) | −0.37 (0.23) |
Ki67 | −0.50 (0.10) | 0.11 (0.74) | −0.55 (0.06) | −0.29 (0.36) |
HIF | 0.08 (0.80) | −0.40 (0.19) | 0.04 (0.91) | −0.10 (0.76) |
Hypoxia score | 0.47 (0.12) | −0.64 (0.03)* | 0.63 (0.03)* | −0.16 (0.63) |
Mid-treatment | ||||
CD31 | −0.09 (0.78) | −0.43 (0.17) | −0.31 (0.32) | −0.32 (0.31) |
Ki67 | −0.43 (0.16) | −0.05 (0.88) | −0.66 (0.02)* | −0.31 (0.33) |
HIF | 0.03 (0.94) | −0.44 (0.16) | −0.10 (0.75) | −0.13 (0.68) |
Hypoxia score | 0.24 (0.45) | −0.63 (0.03)* | 0.58 (0.05) | −0.14 (0.66) |
Post-treatment | ||||
CD31 | −0.15 (0.63) | −0.26 (0.42) | −0.29 (0.36) | −0.13 (0.69) |
Ki67 | −0.57 (0.05) | −0.09 (0.78) | −0.44 (0.16) | −0.04 (0.66) |
HIF | −0.27 (0.40) | −0.20 (0.53) | −0.36 (0.25) | −0.29 (0.37) |
Hypoxia score | 0.23 (0.43) | −0.27 (0.40) | 0.34 (0.27) | −0.18 (0.57) |
ADC, apparent diffusion coefficient; AUC, area under the curve; HIF, hypoxia inducible factor.